Prostate Cancer - Results from #24340

Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: Results of a 2-year follow-up study - Abstract April 13, 2011

The patient after radical prostatectomy : Complexity and efficiency of a urological rehabilitation program - Abstract April 13, 2011

Durable remission of leptomeningeal metastases from hormone-responsive prostate cancer - Abstract April 13, 2011

Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: Implications for prostate cancer risk - Abstract April 13, 2011

Current perspectives on Gleason grading of prostate cancer - Abstract April 13, 2011

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy - Abstract April 13, 2011

Role of second-line systemic treatment post-docetaxel in metastatic castrate resistant prostate cancer- current strategies and future directions - Abstract April 13, 2011

Role of magnetic resonance imaging before initial biopsy: Comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection - Abstract April 13, 2011

Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death and discourages overtreatment April 13, 2011

In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil - Abstract April 12, 2011

Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy - Abstract April 12, 2011

Salvage radical prostatectomy for radiation-recurrent prostate cancer: A multi-institutional collaboration - Abstract April 12, 2011

Magnetic resonance imaging in postprostatectomy radiotherapy planning - Abstract April 12, 2011

Individualized decision-making for older men with prostate cancer: Balancing cancer control with treatment consequences across the clinical spectrum - Abstract April 12, 2011

Metformin in prostate cancer: Two for the price of one - Abstract April 12, 2011

Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer - Abstract April 12, 2011

CURy 2011 - Active surveillance and focal therapy: The concerns - Slide Presentation April 12, 2011

CURy 2011 - Correlation between histological results and MR imaging after vascular targeted photodynamic therapy with TOOKAD® Soluble in focal therapy - Slide Presentation April 12, 2011

CURy 2011 - Tookad Soluble™: A novel FOCAL Vascular Occluding Approach (VOA) for localized prostate cancer - Slide Presentation April 12, 2011

Prostate cancer postoperative nomogram scores and obesity - Abstract April 11, 2011

Page 1218 of 1241

email news signup